학술논문

Increased localization of APP‐C99 in mitochondria‐associated ER membranes causes mitochondrial dysfunction in Alzheimer disease
Document Type
article
Source
The EMBO Journal. 36(22)
Subject
Biochemistry and Cell Biology
Biological Sciences
Alzheimer's Disease
Acquired Cognitive Impairment
Neurosciences
Aging
Neurodegenerative
Alzheimer's Disease including Alzheimer's Disease Related Dementias (AD/ADRD)
Dementia
Brain Disorders
2.1 Biological and endogenous factors
Aetiology
Neurological
Alzheimer Disease
Amyloid Precursor Protein Secretases
Amyloid beta-Protein Precursor
Animals
Cell Line
Cell Respiration
Endoplasmic Reticulum
Humans
Intracellular Membranes
Mice
Mitochondria
Mutation
Oxygen Consumption
Presenilins
Protein Transport
Sphingolipids
Up-Regulation
Alzheimer's disease
C99
MAM
mitochondria and sphingolipids
MAM
Information and Computing Sciences
Medical and Health Sciences
Developmental Biology
Biological sciences
Biomedical and clinical sciences
Language
Abstract
In the amyloidogenic pathway associated with Alzheimer disease (AD), the amyloid precursor protein (APP) is cleaved by β-secretase to generate a 99-aa C-terminal fragment (C99) that is then cleaved by γ-secretase to generate the β-amyloid (Aβ) found in senile plaques. In previous reports, we and others have shown that γ-secretase activity is enriched in mitochondria-associated endoplasmic reticulum (ER) membranes (MAM) and that ER-mitochondrial connectivity and MAM function are upregulated in AD We now show that C99, in addition to its localization in endosomes, can also be found in MAM, where it is normally processed rapidly by γ-secretase. In cell models of AD, however, the concentration of unprocessed C99 increases in MAM regions, resulting in elevated sphingolipid turnover and an altered lipid composition of both MAM and mitochondrial membranes. In turn, this change in mitochondrial membrane composition interferes with the proper assembly and activity of mitochondrial respiratory supercomplexes, thereby likely contributing to the bioenergetic defects characteristic of AD.